GW 842166X Chemical Properties

storage temp. 

Store at -20°C

solubility 

DMF:20.0(Max Conc. mg/mL);44.52(Max Conc. mM)
DMF:PBS (pH 7.2) (1:3):0.25(Max Conc. mg/mL);0.56(Max Conc. mM)
DMSO:37.77(Max Conc. mg/mL);84.07(Max Conc. mM)
Ethanol:0.3(Max Conc. mg/mL);0.67(Max Conc. mM)

form 

Powder

GW 842166X Usage And Synthesis

Description

The peripheral cannabinoid (CB₂) receptor is a G protein-coupled receptor (GPCR) that is localized predominantly in immune cells, monocytes, macrophages, and in several peripheral organs and binds the active component of cannabis, Δ⁹-tetrahydrocannabinol, as well as anandamide, an endogenous CB receptor ligand. GW 842166X is a peripheral cannabinoid (CB₂) receptor agonist with ED₅₀ values of 91 and 63 nM in rat and human, respectively. When administered orally to rats in the Freund’s complete adjuvant (FCA) model of inflammatory pain, GW 842166X is highly potent with an ED₅₀ value of 0.1 mg/kg and full reversal of hyperalgesia at 0.3 mg/kg.

Uses

GW-842166X is pyrimidine ester based compound that is known as a highly selective CB2 receptor agonist for the treatment of inflammatory and neuropathic pain.

Definition

ChEBI: 5-pyrimidinecarboxamide, 2-[(2,4-dichlorophenyl)amino]-n-[(tetrahydro-2h-pyran-4-yl)methyl]-4-(trifluoromethyl)- is a dichlorobenzene.

GW 842166X(666260-75-9)Related Product Information

• CHLOROPHENYLSILANE 97
• Phenylsilane
• Benzeneruthenium(II) chloride dimer
• Phenyl dichlorophosphate
• Phenyltrichlorosilane
• WY-14643
• SIRTINOL
• Rimonabant
• DAPT
• 17-DMAG
• GW 842166X